Literature DB >> 21584829

When a chance to cut is not a chance to cure: a future for palliative surgery?

Paul J Mosca, Dan G Blazer, Jane L Wheeler, Amy P Abernethy.   

Abstract

In the context of healthcare reform, Surgery stands at a critical juncture. Attempting to rein in healthcare spending, legislators and payers can be expected to closely examine the legitimacy and necessity of a variety of medical treatments, including surgical procedures. Among these procedures, the most at risk for dismissal based on perceived ineffectiveness or lack of need may be those performed near the end of life, when the potential benefit of surgical intervention may seem negligible. While procedures may be performed for a variety of reasons toward the end of life--some indeed being inappropriate and/or unnecessary--palliative surgery plays an important role in the management of incurable disease. The purposes of this article are to: describe the place for palliative surgery in the armamentarium of palliative care; discuss potential challenges to patients' access to palliative surgery that may arise from health policy or quality initiatives based on poor evidence; and outline a strategy for (a) systematically differentiating palliative surgeries from other, potentially expendable surgeries performed near the end of life, and (b) defining a plan for generating the evidence base to support best practice.

Entities:  

Mesh:

Year:  2011        PMID: 21584829     DOI: 10.1245/s10434-011-1787-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  2 in total

1.  Communication and palliative care in a 64-year-old man with pancreatic adenocarcinoma.

Authors:  Andrew S Epstein; Ghassan K Abou-Alfa; Ali Shamseddine; Ashwaq Al-Olayan; Celina Ang; Mohamed Naghy; Maeve A Lowery; Eileen M O'Reilly
Journal:  Gastrointest Cancer Res       Date:  2012-07

2.  How do surgeons experience and cope with the death and dying of their patients? A qualitative study in the context of life-limiting illnesses.

Authors:  Sofia C Zambrano; Anna Chur-Hansen; Gregory B Crawford
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.